The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.10
Bid: 43.10
Ask: 46.90
Change: 1.30 (2.97%)
Spread: 3.80 (8.817%)
Open: 43.10
High: 43.10
Low: 43.10
Prev. Close: 43.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BMK08+CleanTreat Update

16 Apr 2021 11:00

RNS Number : 7421V
Benchmark Holdings PLC
16 April 2021
 

16 April 2021

 

Benchmark Holdings

("Benchmark" or the "Company")

 

BMK08+CleanTreatÃ’ Update

 

Ratification of Maximum Residue Limit under European Law

Significant milestone towards the commercialisation of BMK08 and CleanTreatÃ’

 

Further to the notification made on 10 September 2020, Benchmark Holdings is pleased to announce that the MRL (Maximum Residue Limit) for its novel sea lice treatment BMK08 has now been ratified under European Law. The MRL confirms the safety of Benchmark's sea lice solution for consumers and represents a significant milestone in the regulatory approval process towards the anticipated commercial launch of BMK08 and CleanTreatÒ in Norway. The commercial launch remains subject to the grant of a Marketing Authorisation in Norway.

 

BMK08 and CleanTreatÒ is a transformational solution addressing the biggest biological challenge in salmon farming. The MRL EU ratification is the culmination of almost a decade of research and development, a rigorous trial programme and substantial capital investment by Benchmark.

 

Trond Williksen, CEO, commented:

 

"The ratification of the MRL is a further stepping stone towards commercialisation following the announcement of our first customer agreements for CleanTreatâ announced in March.

 

Sea lice continues to be the biggest biological challenge for salmon producers and Benchmark's novel solution addresses this challenge in a sustainable way both in terms of animal welfare and environmental impact."

 

Enquiries:

 

 

Benchmark Holdings plc

Tel: 020 3696 0630

Ivonne Cantu, Investor Relations Director

 

Rachel Aninakwah, Communications

 

 

 

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black / Freddie Barnfield / Duncan Monteith

 

 

 

MHP

 

Katie Hunt /Alistair de Kare-Silver

Tel: 020 3128 8742

benchmark@mhpc.com

 

 

 

 

 

About Benchmark 

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDKABNCBKKAQD
Date   Source Headline
20th Feb 202411:40 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Feb 202410:59 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
15th Feb 20247:00 amRNSQ1 Results
14th Feb 202411:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Feb 20244:00 pmRNSResult of AGM
6th Feb 20244:08 pmRNSForm 8.3 - Benchmark Holdings PLC
6th Feb 20247:36 amRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 20245:30 pmRNSRule 2.9 Announcement
5th Feb 20242:50 pmRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 202410:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
1st Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
1st Feb 202410:16 amRNSForm 8.3 - Benchmark Holdings plc
31st Jan 20242:03 pmRNSForm 8.3 - Benchmark Holdings
31st Jan 20247:00 amRNSTotal Voting Rights
30th Jan 202411:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Jan 202412:18 pmRNSForm 8.3 - Benchmark Holdings plc
26th Jan 20243:19 pmRNSForm 8.3 - Benchmark Holdings Plc - Replacement
26th Jan 202410:48 amRNSForm 8.3 - Benchmark Holdings
26th Jan 20247:00 amRNSForm 8 (OPD) (Benchmark Holdings PLC)
24th Jan 20243:37 pmRNSForm 8.3 - Benchmark Holdings plc - Amendment
24th Jan 20248:46 amRNSForm 8.3 - Benchmark Holdings plc
23rd Jan 20242:40 pmRNSForm 8.3 - Benchmark Holdings Plc
23rd Jan 20242:25 pmRNSForm 8.3 - Benchmark Holdings Plc-Replacement
23rd Jan 20241:57 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - Opening Disclosure - 22 01 2024] - (CGAML)
23rd Jan 202411:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
23rd Jan 20247:00 amRNSNotice of Q1 Results
22nd Jan 20246:02 pmRNSRule 2.9 Announcement
22nd Jan 20245:14 pmRNSForm 8.3 - Benchmark Holdings Plc-Replacement
22nd Jan 20244:27 pmRNSForm 8.3 - Benchmark Holdings Plc
22nd Jan 20241:48 pmRNSForm 8.3 -Benchmark Holdings Plc
22nd Jan 20247:00 amRNSStrategic Review and Formal Sale Process
16th Jan 20245:30 pmRNSNotice of AGM - correction
9th Jan 20245:15 pmRNSPosting of Notice of AGM
12th Dec 20235:50 pmRNSNew Long Term Incentive Plan and PDMR Dealing
12th Dec 20231:54 pmRNSDirectorate Change
7th Dec 202312:00 pmRNSPublication of Annual Report and Notice of AGM
29th Nov 20237:01 amRNSDirectorate Change
29th Nov 20237:01 amRNSQ4 Results
29th Nov 20237:00 amRNSFull Year Results
6th Nov 202310:24 amRNSNotice of Q4 and Full Year Results
31st Oct 20237:00 amRNSTotal Voting Rights
10th Oct 202311:26 amRNSNew salmon broodstock licenses - correction
10th Oct 202310:06 amRNSGrant of two new salmon broodstock licenses
29th Sep 20237:00 amRNSTotal Voting Rights
21st Sep 20237:00 amRNSBlock Listing Six Monthly Return
31st Aug 20237:00 amRNSTotal Voting Rights
24th Aug 20237:00 amRNSQ3 Results
11th Aug 20237:00 amRNSNotice of Q3 Results
31st Jul 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.